患者对肺癌筛查和决策辅助工具的态度。一项调查和焦点小组研究。
Patients' Attitudes Regarding Lung Cancer Screening and Decision Aids. A Survey and Focus Group Study.
机构信息
1 Department of Medicine, Harborview Medical Center, University of Washington, Seattle, Washington.
2 Center to Improve Veteran Involvement in Care, Veterans Affairs Portland Health Care System, Portland, Oregon; Section of Pulmonary and Critical Care Medicine, Veterans Affairs Portland Health Care System, and Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland, Oregon.
出版信息
Ann Am Thorac Soc. 2016 Nov;13(11):1992-2001. doi: 10.1513/AnnalsATS.201604-289OC.
RATIONALE
Little is known about vulnerable patients' perceptions and understanding of, and preferences for, lung cancer screening decision aids.
OBJECTIVES
To determine, in a low-income, racially diverse population, (1) participants' experience, preferences, and reactions to web-based and paper decision aids, and (2) their understanding of harms and benefits of lung cancer screening.
METHODS
We enrolled outpatients at an urban county hospital in six focus group discussions that included review of a web-based and a paper-based lung-cancer screening decision aid. Participants completed surveys before and after the focus groups.
MEASUREMENTS AND MAIN RESULTS
Forty-five patients participated (mean age, 61 yr; 76% current smokers; 24% former smokers); 27% had not completed high school; 50% had an annual income not exceeding $15,000; 42% were nonwhite; and 96% reported chronic illness requiring at least three health care visits yearly. Comparing the proportion with correct answers on pre- and postsurveys, participants' understanding of lung cancer screening increased, particularly of the harms of screening including the potential for false positives, extra testing, and complications. However, after conclusion of the focus groups, more than 50% believed that screening lowered the chance of getting lung cancer. Five major themes emerged from qualitative analyses. Participants (1) were not aware of the purpose of lung cancer screening; (2) wanted to know about the benefits and harms; (3) believed physicians need to communicate more effectively; (4) found decision aids helpful and influential for decision-making about screening; and (5) wanted the discussion to be personalized and tailored. Participants expressed surprise that the magnitude of their lung cancer risk and benefits of screening were lower than anticipated.
CONCLUSIONS
Vulnerable patients find lung cancer screening decision aids helpful and generally show increased knowledge after reviewing decision aids, particularly of harms. Our results can inform future implementation efforts.
背景
对于肺癌筛查决策辅助工具,人们知之甚少,包括弱势患者对其的感知、理解和偏好。
目的
在一个低收入、种族多样化的人群中,确定(1)参与者对基于网络和基于纸质的肺癌筛查决策辅助工具的体验、偏好和反应,以及(2)他们对肺癌筛查的危害和益处的理解。
方法
我们在一家城市县医院招募了 45 名门诊患者,他们参加了六次焦点小组讨论,其中包括对一个基于网络和一个基于纸质的肺癌筛查决策辅助工具的审查。参与者在焦点小组前后都完成了调查。
测量和主要结果
参与者的平均年龄为 61 岁(61 岁);76%为当前吸烟者;24%为前吸烟者;27%未完成高中学业;50%的人年收入不超过 15000 美元;42%为非白人;96%报告患有慢性病,每年至少需要三次医疗就诊。与前后调查的正确答案比例相比,参与者对肺癌筛查的理解有所提高,特别是对筛查的危害有了更多的了解,包括假阳性的可能性、额外的检查和并发症。然而,在焦点小组结束后,超过 50%的人认为筛查降低了患肺癌的几率。从定性分析中出现了五个主要主题。参与者(1)不知道肺癌筛查的目的;(2)想了解收益和危害;(3)认为医生需要更有效地沟通;(4)认为决策辅助工具对筛查决策有帮助和影响力;(5)希望讨论个性化和量身定制。参与者对他们的肺癌风险和筛查收益的程度低于预期感到惊讶。
结论
弱势患者发现肺癌筛查决策辅助工具很有帮助,并且在审查决策辅助工具后普遍表现出更多的知识,特别是对危害的认识。我们的研究结果可以为未来的实施工作提供信息。
相似文献
Ann Am Thorac Soc. 2016-11
Ann Am Thorac Soc. 2016-11
Ann Am Thorac Soc. 2016-11
BMC Med Inform Decis Mak. 2018-1-12
Lung Cancer. 2019-5-1
BMJ Open Respir Res. 2019-11-24
引用本文的文献
Int J Environ Res Public Health. 2024-4-25
Am J Prev Med. 2024-5
Cancers (Basel). 2023-7-29
本文引用的文献
MMWR Morb Mortal Wkly Rep. 2015-11-13
Am J Prev Med. 2015-12
Am J Respir Crit Care Med. 2015-7-15
Am J Respir Crit Care Med. 2015-1-1